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Home-based loop 
Between people with dementia  
and their caregivers 
Sensor-based, context-sensitive,  
evolving, personalised 
offer encouragement,  
warnings, alerts 
Clinician loop 
Faithful log of health-related  
information, 
Summaries, trends, pattern analysis 
Monitor improvement, stasis or 
warn clinician of deterioration  
Supports care decisions 
The Dem@Care Project 
Data Collection in Five Domains 
Person 
with 
Dementia 
SLEEP 
PHYSICAL 
ACTIVITY 
ADL/IADL SOCIAL INTERACTION 
MOOD 
Meal/Drink preparation and 
consumption, daily tasks 
(e.g. watch tv, listen to 
music, read, hobbies, 
chores) 
Night time sleep, awakenings, bed 
exits, Difficulty falling asleep, insomnia 
onset, day-time sleep and napping 
Amount of physical 
activity in the home, 
outside the home, 
dedicated exercise, 
movement speed, 
distance travelled, 
activity intensity 
Observed 
behaviour, physical 
stress levels , 
speech analysis, 
subjective mood 
reporting 
Face-to-face social 
contact, initiated and 
received phone contact, 
speech analysis  
Dem@Home Sensor Toolbox 
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The Dem@Care System 
 Clinician is able to 
monitor 
 Sensors recordings 
 Analysis results (e.g. 
completed activities) from 
the current or previous 
dates/periods 
 
 Person with dementia 
and the carer are able to 
read messages-prompts-
advice that come from  
 The System 
 Clinician  
Dem@Care: Aims and Methodology 
 Research Questions 
 @Lab: Can Dem@Care contribute to the assessment of dementia 
above and beyond traditional assessment methods? 
 @NH: Can Dem@Care effectively support nursing home staff to 
care for people with severe dementia (including BPSD) 
 @Home: Can Dem@Care optimise the functional status of the 
PwD and support their independence and autonomy 
 
 Methodology 
 @Lab: Quantiative between group (Healthy, MCI, AD); n=380 
 @NH and @Home: Multiple case study design; n=13 
 @H: Multiple case study design; n=16 
 Four beneficiary groups  
 the PwD, informal caregivers, the clinician, and formal care staff 
 Stakeholders 
 end-users, academics and professionals, and policy-makers  
 
 Personal Impact:  Quality of life (PwD/Carer) 
 Independence, Sense of Improvement, Security & Safety 
 Social and Economic Impact:  Builds from personal impact 
 Social inclusion, increased understanding of BPSD 
 Early diagnosis increases, staff costs reduce, at home for longer 
 Advance technical, clinical, and ethical state-of-the-art 
 
 
 
 
Personal and Societal Impact 
Personal Impact - People with Dementia 
 Increased autonomy and independence in daily life 
 “I feel kind of in control, do you know what I mean? In control of 
my day.” [@H PwD] 
 Sense of improvement across the five domains addressed 
 “Well I couldn’t imagine that I can wake up after 8 o’clock in the 
morning. I used to wake up before 5 o’clock”   [@H PwD] 
 “I see my father is getting better! He is more active and walking a 
lot”   [@H Carer] 
 “We are talking a lot more now … we are finding it easier to talk”   
[@H Carer] 
 Improved diagnosis and management of care 
 Overall sense of improvement in subjective quality of life 
 
 
 
Personal Impact – Informal Caregivers 
 Key carer concerns: taking medication and eating 
properly, sleep, adequate physical exercise and stimulation 
 Improvements for the person with dementia translated into 
improvements for their informal caregivers 
 “It is a feeling of safety and relief that every caregiver of an elder 
person must have”   [@H Carer] 
 Increased independence for some caregivers 
 “I’m going away for the week in September …. He’s independent at 
the moment as we are trying to keep him as independent as long as 
we can… I used to give him his tablets, now he takes them himself”   
[@H Carer] 
 But, carer independence was most related to the severity of dementia  
 Overall sense of improvement in quality of life 
 “My experience has been brilliant … I found it fantastic” [@H 
Carer] 
 
 
 
 
Personal Impact – Clinicians/Formal Carers 
 Facilitate timely and accurate diagnosis while delivering 
efficiencies in terms of time and cost 
 Improved assessment/diagnostic procedures (incl differential diagnosis) 
 Improvements in clinical reasoning (@NH) 
 Reduction in observer bias 
 More timely identification and better understanding of 
functional, behavioural, and emotion pattern changes 
 “I was able to identify problems and issues [e.g. REM sleep] that otherwise 
would have been impossible” [Clinician] 
 Improved capacity and quality of care. Formal carers can:  
 develop and evaluate personalised interventions 
 better manage the care of the person with dementia 
 better manage the emotional and social disturbances of the Behavioural and 
Psychological Symptoms of Dementia (BPSD) 
 
 
 
 
Societal Impact 
 
 
 
 
 
Societal 
Impact 
Build on 
personal 
improvements 
for each 
beneficiary 
group 
Economic 
Impact 
Personal 
Impact 
for the 
Informal 
Carer 
Personal 
Impact 
for formal 
carers and 
clinicians 
Personal 
Impact 
for the 
PewD 
 Economic: Cost efficiencies  
 Time savings (diagnosis/assessment) 
 Improved workflow, clinical 
reasoning, and intervention selection 
 Potential to reduce costs for national 
healthcare systems 
 Potential savings in the home 
environment – harder to quantify 
Difficult to evaluate the longer-term 
economic and societal outcomes but 
successful attainment of personal 
impacts for each stakeholder group 
will, over time, lead to these outcomes 
 
 
 
 Social: Inclusion and awareness 
 Improved understanding of BPSD 
and reduction in social disturbance 
and therefore isolation @NH 
 Manage appointments and remain 
connected with life outside the home 
 Engagement with new social groups 
 Project dissemination activities 
 
 
 
Scientific Impact: Advancing Technical SoA 
 Novel visual-sensing algorithms 
 New approaches for perceptual analysis of egocentric video content 
 Advanced physiological sensing and audio sensing 
 Highly accurate real-time event detection and people tracking 
 Creation of new knowledge structures, reasoning methods, 
rules, associations, and algorithms 
 Intelligent machine learning and dynamic model adaptation 
 Novel context-aware multi-sensor, intelligent, event-driven 
feedback mechanisms 
 Adaptive visualisations of daily activities 
 Personalised alerts enabling scheduled problem checks and other 
automated interventions 
 Integration and orchestration of sensing analysis and clinical 
applications 
 
 
 
 
Scientific Impact: Advancing Clinical SoA 
 Novel and holistic solution supporting all aspects of the 
clinical management of dementia  
 Assessment and diagnosis 
 Improved early detection of dementia over and above traditional 
assessment methods alone – ability to detect subtle behaviour changes 
 Successfully differentiate between healthy, MCI and AD patients 
 Improved assessment of circumstances surrounding BPSD and their 
contribution to the expression of BPSD for an individual 
 Treatment and care 
 Preventative care decision-making 
 Timely updating of care plans for the person with dementia 
 Potential to support clinical trials 
 Selection and enrolment of participants 
 Support assessment in more ecologically valid environments 
 
 
 
 
 Informed consent 
 High-tech nature of AAL may make it difficult for the PwD to fully 
understand what they are consenting to => Rolling consent 
 Ambient monitoring requires additional third party consent – no 
agreement in the literature as to how this should be handled 
 Privacy and surveillance 
 Impaired cognitive status does lead to situations where data is captured 
that the PwD would not want to be captured 
 Risk of surveillance when monitoring ADLs or monitoring off-site 
 Carers do not always understand the ethical implications 
 Best interests of the person with dementia 
 Risk of replacing or reducing human interaction 
 Discussion time with clinicians needs to be preserved 
 Importance of therapeutic face-to-face contact highlighted @H 
Scientific Impact: Advancing Ethical Debate 
Conclusions 
 Value of objective ongoing assessment 
 Analysis of sensor level data shows promising results although the 
real value of the Dem@Care system is the ability to: 
 Triangulate data from various sensors measuring varied domains 
 Identify improvement, stasis, and/or deterioration over time  
 
 Supports that enable Dem@Home use 
 Easy to use sensors, data transfer, and automated feedback 
 Caregiver is still required as primary source of support 
 Clinician needs to make the effort to ensure that people understand 
how ICT can and may not help, and that informed consent is given 
 Importance of well-supported training periods 
 Importance of personal interaction with the clinician (or researcher) 
 Perceived benefits must be stronger than the perceived effort to use 
the technology 
Conclusions 
 Personal impacts found for all beneficiaries and stakeholders 
 Value of objective ongoing assessment/triangulation of data 
 Improved clinical assessment of a person’s cognitive, functional, and 
emotional status in a familiar environment 
 Supports ongoing monitoring of improvement, stasis, or decline 
 Individualisation of interventions and treatment plans 
 Improvements for person with MCI/dementia based on feedback and 
monitoring 
 Potential for increased carer independence 
 
 Advancement of technical, clinical and ethical state of the art 
 
 But, difficult to evaluate economic and social impacts as:  
 Not all projects include a health economics element 
 Projects typically don’t run for long enough (esp. development projects) 
 Need to develop short-term metrics that we know deliver benefits in the 
longer-term 
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